StockData
CURLFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Curaleaf Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$7.63−0.20 (-2.55%)

Close on Oct 19, 2026

Market cap
$2.07B
P/E (TTM)
–
Dividend yield
–

Curaleaf Holdings, Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Curaleaf does not break out revenue by segment, region or product in the tagged data of its filings for this period type.